Vibio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vibio - overview
Established
2025
Location
Yangzhou, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Founded in 2025 and based in Yangzhou, China, Vibio focuses on the research and development of high-end medical devices. The company aims to address clinical needs through technological innovation and product iteration. In October 2025, Vibio raised Angel funding from new investor Shanghai Deguan Asset Management. The company develops innovative medical devices tailored to clinical applications.
The company focuses on breakthrough technologies that enhance patient outcomes and improve healthcare delivery. Its product pipeline includes intelligent diagnostic tools and next-generation therapeutic equipment. Revenue is generated through the sale of proprietary medical devices, clinical partnerships, and potential licensing of its technologies. The company also engage in pilot programs with hospitals and healthcare providers.
Current Investors
Shanghai Deguan Asset Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.